Biofrontera gets FDA approval for Ameluz red-light PDT
Biofrontera said the FDA approved Ameluz topical gel with RhodoLED red-light photodynamic therapy for treating superficial basal cell carcinoma in adults.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.